Abstract
Hybrid therapeutic gene FCU1 gene was cloned into a lentiviral expression vector and the therapeutic effect of its expression was studied in three pancreatic cancer cell lines. Expression of FCU1 gene sensitized cells of two of three studied pancreatic cancer cell lines to 5-fluorocytosine. In addition, uracil phosphoribosyl transferase activity of the hybrid FCU1 protein increased sensitivity of transfected cells of all three studied pancreatic cancer cell lines to 5-fluorouracil, a standard chemotherapeutic agent.
Keywords:
5-fluorocytosine; 5-fluorouracil; gene therapy; pancreatic cancer.
MeSH terms
-
Antineoplastic Agents / pharmacology*
-
Cell Line, Tumor
-
Cytosine Deaminase / genetics*
-
Cytosine Deaminase / metabolism
-
Drug Resistance, Neoplasm
-
Flucytosine / metabolism
-
Flucytosine / pharmacology
-
Fluorouracil / pharmacology
-
Gene Expression
-
Genetic Vectors / chemistry
-
Genetic Vectors / metabolism
-
Humans
-
Insulin-Secreting Cells / drug effects*
-
Insulin-Secreting Cells / metabolism
-
Insulin-Secreting Cells / pathology
-
Lentivirus / genetics
-
Lentivirus / metabolism
-
Pentosyltransferases / genetics*
-
Pentosyltransferases / metabolism
-
Plasmids / chemistry
-
Plasmids / metabolism
-
Recombinant Fusion Proteins / genetics*
-
Recombinant Fusion Proteins / metabolism
-
Transduction, Genetic
Substances
-
Antineoplastic Agents
-
Recombinant Fusion Proteins
-
Flucytosine
-
Pentosyltransferases
-
uracil phosphoribosyltransferase
-
Cytosine Deaminase
-
Fluorouracil